collection
MENU ▼
Read by QxMD icon Read
search

Retrievable IVC filters dont prevent recurrent symptomatic PE

shared collection
2 papers 0 to 25 followers
By Jason Mann No BS pulmonary critical care fellow
https://www.readbyqxmd.com/read/16009794/eight-year-follow-up-of-patients-with-permanent-vena-cava-filters-in-the-prevention-of-pulmonary-embolism-the-prepic-prevention-du-risque-d-embolie-pulmonaire-par-interruption-cave-randomized-study
#1
RANDOMIZED CONTROLLED TRIAL
(no author information available yet)
BACKGROUND: In a randomized trial in patients with proximal deep-vein thrombosis, permanent vena cava filters reduced the incidence of pulmonary embolism but increased that of deep-vein thrombosis at 2 years. An 8-year follow-up was performed to assess their very long-term effect. METHODS AND RESULTS: Four hundred patients with proximal deep-vein thrombosis with or without pulmonary embolism were randomized either to receive or not receive a filter in addition to standard anticoagulant treatment for at least 3 months...
July 19, 2005: Circulation
https://www.readbyqxmd.com/read/25919526/effect-of-a-retrievable-inferior-vena-cava-filter-plus-anticoagulation-vs-anticoagulation-alone-on-risk-of-recurrent-pulmonary-embolism-a-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Patrick Mismetti, Silvy Laporte, Olivier Pellerin, Pierre-Vladimir Ennezat, Francis Couturaud, Antoine Elias, Nicolas Falvo, Nicolas Meneveau, Isabelle Quere, Pierre-Marie Roy, Olivier Sanchez, Jeannot Schmidt, Christophe Seinturier, Marie-Antoinette Sevestre, Jean-Paul Beregi, Bernard Tardy, Philippe Lacroix, Emilie Presles, Alain Leizorovicz, Hervé Decousus, Fabrice-Guy Barral, Guy Meyer
IMPORTANCE: Although retrievable inferior vena cava filters are frequently used in addition to anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is unclear. OBJECTIVE: To evaluate the efficacy and safety of retrievable vena cava filters plus anticoagulation vs anticoagulation alone for preventing pulmonary embolism recurrence in patients presenting with acute pulmonary embolism and a high risk of recurrence. DESIGN, SETTING, AND PARTICIPANTS: Randomized, open-label, blinded end point trial (PREPIC2) with 6-month follow-up conducted from August 2006 to January 2013...
April 28, 2015: JAMA: the Journal of the American Medical Association
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"